|
|
|
시장보고서
US and European Urologist Survey: Prostate Cancer Treatment Trends 2008
|
Abstract
The majority of US and European respondents indicate that the following
prostate cancer treatments are used at an appropriate rate: chemotherapy,
hormone therapy, radiation therapy, and radical prostatectomy.
Table of Contents
Survey Questions
Geographical Stratification
- Please identify where you currently practice.
Facility Information
- Question: Which of the following best describes your facility?
- »Teaching hospital, nonteaching hospital, small group practice,
large group practice, solo practice, ambulatory service center (ASC)
Respondent Information
- Question: How many years have you been in practice (post
residency/fellowship)?
- Question: Please identify the average age of your patients.
Insights on Prostate Cancer Treatment Options
- Question: In general, how do you feel about the current rate of use
for each of these prostate cancer treatments?
- »Chemotherapy, cryosurgery, HIFU, hormone therapy, radiation
therapy, radical prostatectomy, other
- »Overused, underused, used at an appropriate rate, no opinion
- Question: Of the underused prostate cancer treatments, which of the
following barriers is the most significant to impending greater adoption?
- »Concerned about liability, insufficient quality of life data,
insufficientpatient outcomedata, insufficient reimbursement, limitedsupport
from company or sales representative, must refer patients to other physician
outside my practice, prefer other procedures that provide comparable
outcomes, prefer other procedures that provide comparable quality of life
Penetration of Prostate Cancer Treatment Options
- Question: Which of these treatment options do you currently use or
refer prostate cancer patients for?
- Please select all that apply.
- »Chemotherapy, cryosurgery, high dose rate (HDR) brachytherapy,
HIFU, hormone therapy, interstitial brachytherapy, radiation therapy (EBRT
or IMRT), radical prostatectomy, watchful waiting, other
- Question: Please indicate changes in your treatment frequency over
the past year for each treatment option you currently
- use or refer prostate cancer patients for.
- »Significantly decreased, decreased, no change, increased,
significantly increased
- Question: Of your patients who are treated with interstitial
brachytherapy, what percentage (%) received the following seeds?
- Also, please indicate changes in treatment frequency over the past year.
- »I - 125 seed, Pd - 103 seed, Cs - 137 seed
- »Significantly decreased, decreased, no change, increased,
significantly increased
Future Adoption of Treatment Options
- Question: Of the treatment options that you do not currently useor
refer patients for, which do you plan on adopting in the future? Please select
all that apply.
- »Chemotherapy, cryosurgery, high dose rate (HDR) brachytherapy,
HIFU, hormone therapy, interstitial brachytherapy, radiation therapy (EBRT
or IMRT), radical prostatectomy, watchful waiting, other
- Question: When do you think you will adopt each treatment?
- »Within 1 year, within 1 - 2 years, in more than 2 years
- Question: Why are you planning to adopt each treatment?
- »Better reimbursement, fewer post - procedural complications,
shorter post - procedure recovery period than alternatives, superior
clinical results, training provided by companies
Awareness of New Treatment Options
- Question: Are you aware of any of the following new treatments, or
treatments in development, for patients who suffer from prostate cancer?
(Please select all that apply).
- »Autoimmune therapy, gene therapy, HIFU, transperineal microwave
ablation of the prostate (TAP), other
- Question: How do you think the new treatments will impact the way
patients who suffer from prostate cancer are treated?
- »This will decrease the cost of treating a patient, this will
decrease patient recovery times, this will improve patient outcomes, this
will increase the number of patients eligible for treatment, this will make
treatments more accessible to patients
|
 |
